Cargando…
Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial
BACKGROUND: The clinical effects of mucolytics in patients with chronic obstructive pulmonary disease (COPD) are discussed controversially. Cineole is the main constituent of eucalyptus oil and mainly used in inflammatory airway diseases as a mucolytic agent. We hypothesised that its known mucolytic...
Autores principales: | Worth, Heinrich, Schacher, Christian, Dethlefsen, Uwe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720945/ https://www.ncbi.nlm.nih.gov/pubmed/19624838 http://dx.doi.org/10.1186/1465-9921-10-69 |
Ejemplares similares
-
Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial
por: Fischer, Juergen, et al.
Publicado: (2013) -
Gastroprotective Mechanisms of the Monoterpene 1,8-Cineole (Eucalyptol)
por: Rocha Caldas, Germana Freire, et al.
Publicado: (2015) -
New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach
por: Juergens, Lisa Joy, et al.
Publicado: (2020) -
1,8-Cineol (Eucalyptol) Disrupts Membrane Integrity and Induces Oxidative Stress in Methicillin-Resistant Staphylococcus aureus
por: Merghni, Abderrahmen, et al.
Publicado: (2023) -
Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation
por: Venkataraman, Balaji, et al.
Publicado: (2023)